Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,208
Sort by:

Leading Animal Health Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,850.00

This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for:Assessment of major U.S. and international trends with potentially significant impac...

November 2021 -

Leading Generic and Specialty Drug Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 9,500.00

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions an...

November 2021 -

Leading Pharmaceutical Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological...

November 2021 -

Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

US$ 2,600.00

Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor gro...

November 2021 40 pages

Research Report on China's Bicalutamide Market, 2021-2025

US$ 2,600.00

Prostate cancer is one of the common malignant tumors in men. With the development of economy, factors like increasing environmental pollution, changing lifestyle, and aging population has caused the...

November 2021 40 pages

Pharmaceutical Processing Seals Market by Material (Metals, PTFE, Nitrile Rubber, Silicone, EPDM, FKM, FFKM, UHMWPE, PU), Type (O-Ring Seals, Gaskets, Lip Seals, D Seals), Application (Manufacturing Equipment), and Region - Global Forecast to 2026

US$ 2,970.00

... the pharmaceutical processing seals market. “O-rings accounted for the largest market share in pharmaceutical processing seals market.” O-rings accounted for the largest market share in the pharmaceutical processing seals market. O-rings are used in pharmaceutical equipment ...

November 2021 165 pages

U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End-use (Pharma, Biotech), And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 48 Business Hours U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Growth & Trends The U.K. biotechnology and pharmaceutical service...

November 2021 100 pages

Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccines), Valence (Multivalent, Monovalent) - Global Forecast to 2028

US$ 4,175.00

Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccin...

November 2021 229 pages

Antifungal Drugs: Technologies and Global Markets

US$ 5,500.00

This antifungal drugs report by BCC Research analyzes the global human antifungal market and assess its growth potential over the five-year period from 2016 to 2021.

November 2021 295 pages

Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026

US$ 3,750.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Active Pharmaceutical Ingredients Market Report The active pharmaceutical ingredients market is expected to...

November 2021 284 pages

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute...

October 2021 2145 pages

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Drugs In Development...

October 2021 304 pages

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Drugs In D...

October 2021 97 pages

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spond...

October 2021 295 pages

Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Drugs In De...

October 2021 305 pages

Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperpla...

October 2021 109 pages

Cervical Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Cervical Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provid...

October 2021 2171 pages

Chondrosarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Chondrosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Drugs In Development, 2021, provides...

October 2021 727 pages

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia - Dr...

October 2021 1872 pages

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic...

October 2021 815 pages

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021

US$ 3,500.00

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Cyclin Depende...

October 2021 110 pages

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Drugs In Development, 2021,...

October 2021 137 pages

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers - Drugs In Devel...

October 2021 218 pages

Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy - Drugs In Develop...

October 2021 149 pages

Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Devel...

October 2021 424 pages

Endometrial Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Endometrial Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2021,...

October 2021 2259 pages

Ewing Sarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Ewing Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma - Drugs In Development, 2021, provides a...

October 2021 938 pages

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021

US$ 3,500.00

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021 SUMMARY Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor o...

October 2021 65 pages

Gallbladder Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gallbladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Drugs In Development, 2021,...

October 2021 1118 pages

Gingivitis (Mouth and Dental Disorders) - Drugs in Development, 2021

US$ 2,000.00

Gingivitis (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gingivitis - Drugs In Development, 2021...

October 2021 37 pages

Gliosarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gliosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Drugs In Development, 2021, provides an ov...

October 2021 575 pages

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Drugs In Development...

October 2021 156 pages

Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021

US$ 3,500.00

Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021 SUMMARY Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 10 molecules. Out of which approximately 4 molecul...

October 2021 36 pages

Herpes Labialis (Oral Herpes) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Herpes Labialis (Oral Herpes) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis - Drugs In D...

October 2021 61 pages

Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heterozy...

October 2021 123 pages

Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Drugs In Devel...

October 2021 329 pages

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021

US$ 3,500.00

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Insulin Like Growth Factor I - Drugs In D...

October 2021 58 pages

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021

US$ 3,500.00

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021 SUMMARY Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor...

October 2021 48 pages

Kaposi Sarcoma (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Kaposi Sarcoma (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kaposi Sarcoma - Drugs In Development, 2021...

October 2021 468 pages

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Drugs in Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Drugs in Development, 2021 SUMMARY Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 m...

October 2021 63 pages

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Drugs in Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Drugs in Development, 2021 SUMMARY Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Metabotropic glutamate receptor 3 is a...

October 2021 43 pages

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Metabotropic Glutamate Receptor 5 - Drugs In Development,...

October 2021 82 pages

Muscular Dystrophy (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Muscular Dystrophy (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy - Drugs In Development,...

October 2021 330 pages

Neuroblastoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Neuroblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma - Drugs In Development, 2021, provides a...

October 2021 1265 pages

Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development, 20...

October 2021 4641 pages

Obesity (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,500.00

Obesity (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an...

October 2021 763 pages

Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Drugs In Development, 2021, pro...

October 2021 33 pages

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synov...

October 2021 86 pages

Pontine Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Pontine Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Drugs In Development, 2021, provides...

October 2021 649 pages

Progressive Multifocal Leukoencephalopathy (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Progressive Multifocal Leukoencephalopathy (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Mul...

October 2021 47 pages

Filters

Search

Categories

152
14,608
11,952
339
73
1,084

Publishers

72
1
1,760
342
469
292
33
4
1,887
635
92
3,251
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
139
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
82
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
25,602

Price

—

Date

—

Pages

—

Offers

44
5
1